Open AccessHuman epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas
Author(s) -
Kiyoshi Hasegawa,
Kato,
Ishii Ishii,
Owaki,
Torii,
Oe,
Hirasawa,
Kobayashi,
Udagawa
Publication year - 2013
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s47504
Subject(s) - human epidermal growth factor receptor 2 , epidermal growth factor receptor , oncology , cancer research , medicine , receptor , pathology , cancer , breast cancer
Human epidermal growth factor receptor (HER)-2 overexpression or gene amplification is more common in high-grade or type 2 endometrial carcinomas. We assessed the discordance of HER-2 expression between primary and metastatic or recurrent endometrial carcinomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom